OncoSec Medical IncのROIC
OncoSec Medical IncのROICは何ですか。
OncoSec Medical IncのROICは-95.95%です。
ROICの定義は何ですか。
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
NASDAQのセクタHealth CareにおけるROICの企業と比べるOncoSec Medical Inc
OncoSec Medical Incは何をしますか。
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
OncoSec Medical Incと類似のroic
- Talga ResourcesのROICは-96.26%です。
- LoopのROICは-96.17%です。
- IGC Pharma IncのROICは-96.01%です。
- Emerita Resources CorpのROICは-96.01%です。
- Beyond AirのROICは-95.98%です。
- Trillium Gold MinesのROICは-95.97%です。
- OncoSec Medical IncのROICは-95.95%です。
- N4 Pharma PlcのROICは-95.50%です。
- Errawarra Resources LtdのROICは-95.41%です。
- Nostrum Oil & Gas PlcのROICは-95.35%です。
- Ondine BiomedicalのROICは-95.25%です。
- DBV Technologies SAのROICは-95.12%です。
- SenSen NetworksのROICは-95.08%です。